Literature DB >> 13109111

Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. II. Studies on the nature of the active serum constituent: histological mechanism of the regression: tests for effects of guinea pig serum on lymphoma cells in vitro: discussion.

J G KIDD.   

Abstract

In an extension of the experimental studies recorded in an associated paper; attempts were made to isolate and characterize the constituent of guinea pig serum responsible for inducing regression of transplanted lymphomas in vivo. The active material was precipitated readily from the whole serum, along with some of the globulins, by means of ammonium sulfate in concentrations of 2.0 molar or greater; it withstood heating at 56 degrees C. for 20 or 30 minutes, but was inactivated upon heating at 66 degrees C. for similar periods; it was completely inactivated by chymotrypsin in concentrations of 1 or 2 mg./cc. during 6 hours at 37 degrees C. Furthermore, the inhibitory effects of small amounts of the guinea pig serum in vivo were enhanced upon admixture with immune sera prepared by injecting the lymphosarcoma cells into rabbits. The facts as a whole suggest that the active material is a protein, and that it may be one or another of the components of complement; yet they do not suffice to establish its identity. Microscopic studies showed that the cells of subcutaneous lymphomas rapidly died and were resorbed following injections of relatively large amounts of guinea pig serum intraperitoneally into mice carrying them, while similar changes followed more gradually after repeated injections of smaller amounts of guinea pig serum. No changes referable to the guinea pig serum were seen in the normal tissues or organs of mice receiving it. Mouse lymphoma cells, suspended artificially as individuals in a physiological saline solution, regularly remained viable following incubation in vitro in mixture with guinea pig serum during 6 hours at 37 degrees C. The finding provides strong evidence that the regression of lymphomas that follows injection of guinea pig serum in vivo is brought about through some reaction in which the guinea pig serum and the host both participate. Some of the implications of the findings are discussed.

Entities:  

Keywords:  LYMPHOMA/experimental; NEOPLASMS/transplantation

Mesh:

Substances:

Year:  1953        PMID: 13109111      PMCID: PMC2136338          DOI: 10.1084/jem.98.6.583

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Observations on the effect of a folic-acid antagonist on transplantable lymphoid leukemias in mice.

Authors:  L W LAW; T B DUNN
Journal:  J Natl Cancer Inst       Date:  1949-08       Impact factor: 13.506

2.  Microelectrophoresis of protein on filter-paper.

Authors:  F V FLYNN; P DE MAYO
Journal:  Lancet       Date:  1951-08-11       Impact factor: 79.321

3.  Effect of alpha-peltatin, beta-peltatin, podophyllotoxin on lymphomas and other transplanted tumors.

Authors:  E M GREENSPAN; J LEITER; M J SHEAR
Journal:  J Natl Cancer Inst       Date:  1950-06       Impact factor: 13.506

4.  Presence of complement in serum of the mouse.

Authors:  R B McGHEE
Journal:  Proc Soc Exp Biol Med       Date:  1952-07

5.  Ocular lesions induced by acute exposure of the whole body of newborn mice to roentgen radiation.

Authors:  E LORENZ; T B DUNN
Journal:  Arch Ophthal       Date:  1950-04

6.  Studies on the mechanism of action of chemotherapeutic agents in cancer. IV. Relationship of guanine and guanylic acid to the action of guanazolo on lymphoid tumors in mice and rats.

Authors:  A GOLDIN; E M GREENSPAN; E B SCHOENBACH
Journal:  J Natl Cancer Inst       Date:  1950-10       Impact factor: 13.506

7.  Structural changes produced in Brown-Pearce carcinoma cells by means of a specific antibody and complement.

Authors:  B KALFAYAN; J G KIDD
Journal:  J Exp Med       Date:  1953-01       Impact factor: 14.307

8.  EXPERIMENTAL HYPOALBUMINEMIA : ITS EFFECT ON THE MORPHOLOGY, FUNCTION, AND PROTEIN AND WATER CONTENT OF THE LIVER.

Authors:  R Elman; C J Heifetz
Journal:  J Exp Med       Date:  1941-02-28       Impact factor: 14.307

9.  A COMPARISON OF HUMAN AND GUINEA PIG COMPLEMENTS AND THEIR COMPONENT FRACTIONS.

Authors:  O G Bier; G Leyton; M M Mayer; M Heidelberger
Journal:  J Exp Med       Date:  1945-05-01       Impact factor: 14.307

  9 in total
  33 in total

Review 1.  [L-asparaginase and leukemia].

Authors:  E Grundmann
Journal:  Klin Wochenschr       Date:  1969-01-15

2.  [Immunosuppressive effect of L-asparaginase in the tuberlin reaction of guinea pigs].

Authors:  W P Madaus
Journal:  Klin Wochenschr       Date:  1969-11-15

3.  Conditions for the production of L-asparaginase 2 by coliform bacteria.

Authors:  M H Bilimoria
Journal:  Appl Microbiol       Date:  1969-12

4.  Production of L-asparaginase II by Escherichia coli.

Authors:  H Cedar; J H Schwartz
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

5.  [Detection of antibody blocking by L-asparaginase by means of the agar plaque technic].

Authors:  W P Madaus
Journal:  Klin Wochenschr       Date:  1970-02-15

6.  The effect of natural antibody in guinea-pig serum on mouse lymphoma cells in vitro and in vivo.

Authors:  J D Wakefield; J R Batchelor
Journal:  Immunology       Date:  1966-11       Impact factor: 7.397

7.  [The influence of E. coli-L-asparaginase on the course of the experimental guinea pig tuberculosis].

Authors:  E Schwartz; L Badalik
Journal:  Pneumonologie       Date:  1970

Review 8.  Biochemical Underpinnings of Immune Cell Metabolic Phenotypes.

Authors:  Benjamin A Olenchock; Jeffrey C Rathmell; Matthew G Vander Heiden
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

9.  Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes.

Authors:  Z B Moola; M D Scawen; T Atkinson; D J Nicholls
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

10.  First-line treatment of acute lymphoblastic leukemia with pegasparaginase.

Authors:  Riccardo Masetti; Andrea Pession
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.